Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AK › Nome › NPI 1225101041
Hospital

Norton Sound Health Corporation

Norton Sound Health Corporation was paid $63.29M by Medicaid between Jan 2018 and Dec 2024, across 196 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 16% of everything it billed.

33Billing provider infoNORTON SOUND HEALTH CORPORATION
NOME, AK 99762
33aNPI1225101041assigned 11/17/2006
33bProvider typeCritical Access Hospital
28Total paid$63.29M
24GClaims382,897
24DCodes billed196
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Alaska

Rank by total paid#1 of 8
Median peer was paid$17.70M
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201844,812$7.52M
201950,260$9.01M
202047,399$8.12M
202181,362$12.24M
202264,261$10.77M
202353,002$8.24M
2024incomplete41,801$7.38M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 16% 65,238 43,067 $10.36M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.2% 6,145 4,591 $5.83M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.9% 10,346 7,887 $5.61M
80053 Comprehensive metabolic panel 4.7% 15,245 12,778 $2.98M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3.5% 13,895 10,726 $2.19M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.9% 11,316 10,455 $1.84M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.8% 16,049 13,496 $1.75M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 5,667 4,403 $1.75M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 1,251 982 $1.61M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.4% 7,607 6,990 $1.51M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.3% 7,520 6,921 $1.48M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.8% 400 347 $1.17M
184 more codes
70450 Computed tomography, head or brain; without contrast material 1.8% 821 $1.16M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 2,803 $925K
84443 Thyroid stimulating hormone (TSH) 1.4% 5,461 $904K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.4% 3,681 $892K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.4% 565 $878K
71046 Radiologic examination, chest; 2 views 1.3% 2,304 $827K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 3,524 $798K
81025 1.2% 8,496 $749K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 2,370 $699K
83036 Hemoglobin; glycosylated (A1C) <1% 5,049 $617K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,733 $611K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,311 $610K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,156 $585K
J3490 Unclassified drugs <1% 3,147 $576K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,673 $538K
81001 <1% 6,796 $525K
96375 Therapeutic injection; each additional sequential IV push <1% 2,418 $499K
96361 Intravenous infusion, hydration; each additional hour <1% 2,758 $493K
85018 <1% 8,652 $491K
80061 Lipid panel <1% 3,731 $464K
81002 <1% 11,178 $460K
82948 <1% 6,132 $420K
86141 <1% 3,008 $393K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 1,412 $362K
86803 <1% 1,868 $360K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,508 $354K
87210 <1% 3,783 $347K
82728 <1% 1,923 $338K
97161 <1% 1,306 $295K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,515 $273K
87186 <1% 1,987 $266K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 320 $259K
83880 <1% 1,149 $254K
83735 <1% 3,406 $250K
80048 Basic metabolic panel (calcium, ionized) <1% 1,346 $240K
86780 <1% 2,212 $237K
80305 <1% 1,615 $237K
83690 <1% 2,620 $208K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,501 $192K
85027 <1% 1,796 $180K
80306 <1% 1,400 $179K
84484 <1% 1,417 $178K
84466 <1% 1,544 $176K
86481 <1% 672 $174K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 61 $156K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 497 $151K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 754 $151K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 8,011 $150K
87807 <1% 1,055 $139K
77067 Screening mammography, bilateral, including computer-aided detection <1% 575 $133K
83540 <1% 1,730 $128K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,542 $127K
71045 Radiologic examination, chest; single view <1% 541 $126K
73610 <1% 283 $124K
87340 <1% 988 $124K
85610 <1% 1,642 $106K
86850 <1% 980 $106K
99213 Doctor's office visit, returning patient (routine) <1% 5,071 $94K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,147 $91K
84702 <1% 549 $88K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 272 $84K
85652 <1% 1,569 $83K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 645 $79K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 605 $79K
87486 <1% 597 $79K
87581 <1% 597 $78K
77063 Screening digital breast tomosynthesis, bilateral <1% 549 $77K
82977 <1% 1,091 $76K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 338 $73K
72125 Computed tomography, cervical spine; without contrast material <1% 47 $69K
73130 <1% 164 $67K
86480 <1% 248 $66K
84439 <1% 498 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 141 $64K
73562 <1% 168 $61K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,617 $61K
86900 <1% 1,017 $59K
J2510 Injection, penicillin g procaine, aqueous, up to 600,000 units <1% 119 $53K
73030 <1% 124 $53K
80076 <1% 352 $50K
36415 Collection of venous blood by venipuncture <1% 5,667 $49K
G0378 Hospital observation service, per hour <1% 17 $48K
86901 <1% 1,017 $48K
76801 <1% 100 $48K
85730 <1% 464 $47K
83605 <1% 457 $46K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 170 $45K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 668 $45K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 210 $44K
86702 <1% 2,328 $43K
87070 <1% 312 $42K
86762 <1% 328 $41K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,076 $41K
82550 <1% 391 $40K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,278 $38K
82607 <1% 367 $38K
J2315 Injection, naltrexone, depot form, 1 mg <1% 14 $35K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,085 $32K
J7050 Infusion, normal saline solution, 250 cc <1% 1,255 $30K
84703 <1% 339 $29K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 799 $27K
84100 <1% 426 $27K
73100 <1% 65 $26K
86701 <1% 2,328 $24K
70486 <1% 12 $24K
84145 <1% 311 $22K
87081 <1% 203 $22K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,018 $21K
83721 <1% 1,192 $19K
J2060 Injection, lorazepam, 2 mg <1% 493 $18K
99214 Doctor's office visit, returning patient (more involved) <1% 588 $16K
J2270 Injection, morphine sulfate, up to 10 mg <1% 899 $13K
82746 <1% 97 $13K
85014 <1% 333 $11K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 74 $11K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 175 $10K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 640 $9K
73630 <1% 28 $9K
83719 <1% 176 $9K
87040 <1% 43 $9K
87150 <1% 59 $8K
86706 <1% 53 $8K
73090 <1% 14 $8K
82570 <1% 94 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 301 $7K
80074 <1% 17 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 121 $6K
84512 <1% 88 $6K
96376 <1% 30 $6K
87390 <1% 502 $6K
82565 <1% 45 $5K
83550 <1% 77 $5K
84153 <1% 28 $4K
85007 <1% 79 $4K
86704 <1% 41 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 878 $4K
85379 <1% 28 $4K
83655 <1% 27 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 64 $4K
82951 <1% 26 $4K
82435 <1% 28 $4K
86703 <1% 37 $3K
86431 <1% 25 $3K
84132 <1% 44 $3K
84295 <1% 44 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 42 $3K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 72 $3K
82310 <1% 28 $3K
84075 <1% 25 $2K
99152 <1% 45 $2K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 31 $2K
82040 <1% 24 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 108 $2K
82947 <1% 36 $2K
J3411 Injection, thiamine hcl, 100 mg <1% 59 $2K
92504 <1% 21 $2K
82247 <1% 42 $2K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 128 $2K
82105 <1% 13 $2K
86708 <1% 12 $2K
84520 <1% 28 $2K
84460 <1% 26 $1K
84155 <1% 24 $1K
84450 <1% 24 $1K
92567 <1% 85 $1K
V2750 Anti-reflective coating, per lens <1% 69 $1K
V2020 Frames, purchases <1% 43 $776.54
82043 <1% 15 $541.76
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 79 $449.81
90715 <1% 16 $401.68
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 196 $239.43
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 156 $181.57
V2745 Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens <1% 26 $130.87
J1630 Injection, haloperidol, up to 5 mg <1% 156 $32.80
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,627 $24.56
90647 <1% 12 $0.12
0202U Oncology (prostate), multianalyte, gene expression profiling 0% 680 $0.00
87634 0% 2,178 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 14 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 39 $0.00
90670 0% 16 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 47 $0.00
0352U 0% 1,086 $0.00
80320 0% 1,446 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGORN, AGNELA (HOSPITAL SERVICES VP)
Parent organizationCRITICAL ACESS HOSPITAL